Betaglycan binds inhibin and can mediate functional antagonism of activin signalling KA Lewis, PC Gray, AL Blount, LA MacConell, E Wiater, LM Bilezikjian, ... Nature 404 (6776), 411-414, 2000 | 738 | 2000 |
The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly J Greenwald, J Groppe, P Gray, E Wiater, W Kwiatkowski, W Vale, S Choe Molecular cell 11 (3), 605-617, 2003 | 363 | 2003 |
Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications P Ciarmela, MS Islam, FM Reis, PC Gray, E Bloise, F Petraglia, W Vale, ... Human reproduction update 17 (6), 772-790, 2011 | 331 | 2011 |
Antagonists of activin signaling: mechanisms and potential biological applications CA Harrison, PC Gray, WW Vale, DM Robertson Trends in Endocrinology & Metabolism 16 (2), 73-78, 2005 | 284 | 2005 |
Primary structure and function of an A kinase anchoring protein associated with calcium channels PC Gray, BD Johnson, RE Westenbroek, LG Hays, JR Yates, T Scheuer, ... Neuron 20 (5), 1017-1026, 1998 | 233 | 1998 |
Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins PC Gray, JD Scott, WA Catterall Current opinion in neurobiology 8 (3), 330-334, 1998 | 226 | 1998 |
GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor β signaling and enhance cell growth G Shani, WH Fischer, NJ Justice, JA Kelber, W Vale, PC Gray Molecular and cellular biology 28 (2), 666-677, 2008 | 214 | 2008 |
Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways JA Kelber, AD Panopoulos, G Shani, EC Booker, JC Belmonte, WW Vale, ... Oncogene 28 (24), 2324-2336, 2009 | 205 | 2009 |
Cripto forms a complex with activin and type II activin receptors and can block activin signaling PC Gray, CA Harrison, W Vale Proceedings of the National Academy of Sciences 100 (9), 5193-5198, 2003 | 202 | 2003 |
Identification of a 15-kDa cAMP-dependent protein kinase-anchoring protein associated with skeletal muscle L-type calcium channels PC Gray, VC Tibbs, WA Catterall, BJ Murphy Journal of Biological Chemistry 272 (10), 6297-6302, 1997 | 184 | 1997 |
Identification of a binding site on the type II activin receptor for activin and inhibin PC Gray, J Greenwald, AL Blount, KS Kunitake, CJ Donaldson, S Choe, ... Journal of Biological Chemistry 275 (5), 3206-3212, 2000 | 170 | 2000 |
Tumor microenvironment heterogeneity: challenges and opportunities F Runa, S Hamalian, K Meade, P Shisgal, PC Gray, JA Kelber Current molecular biology reports 3, 218-229, 2017 | 154 | 2017 |
An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors CA Harrison, PC Gray, WH Fischer, C Donaldson, S Choe, W Vale Journal of Biological Chemistry 279 (27), 28036-28044, 2004 | 137 | 2004 |
The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition M Klauzinska, NP Castro, MC Rangel, BT Spike, PC Gray, D Bertolette, ... Seminars in cancer biology 29, 51-58, 2014 | 121 | 2014 |
Cripto binds transforming growth factor β (TGF-β) and inhibits TGF-β signaling PC Gray, G Shani, K Aung, J Kelber, W Vale Molecular and cellular biology 26 (24), 9268-9278, 2006 | 121 | 2006 |
Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis PC Gray, W Vale FEBS letters 586 (14), 1836-1845, 2012 | 117 | 2012 |
Identification of distinct inhibin and transforming growth factor β-binding sites on betaglycan: functional separation of betaglycan co-receptor actions E Wiater, CA Harrison, KA Lewis, PC Gray, WW Vale Journal of Biological Chemistry 281 (25), 17011-17022, 2006 | 105 | 2006 |
Activins and inhibins and their signaling W Vale, E Wiater, P Gray, C Harrison, L Bilezikjian, S Choe Annals of the New York Academy of Sciences 1038 (1), 142-147, 2004 | 104 | 2004 |
AKAP15 anchors cAMP-dependent protein kinase to brain sodium channels VC Tibbs, PC Gray, WA Catterall, BJ Murphy Journal of Biological Chemistry 273 (40), 25783-25788, 1998 | 100 | 1998 |
Patient-derived xenografts and organoids model therapy response in prostate cancer S Karkampouna, F La Manna, A Benjak, M Kiener, M De Menna, E Zoni, ... Nature communications 12 (1), 1117, 2021 | 96 | 2021 |